The Effect of D-cycloserine on Emotional Processing

University of Oxford

Status

Completed

Conditions

Healthy Volunteer

Cycloserine

Treatments

Drug: Placebo

Drug: d-cycloserine

Study type

Interventional

Funder types

Other

Identifiers

NCT03961464

R57491/RE001

Details and patient eligibility

About

To investigate the effects of N-methyl-D-aspartate (NMDA) partial agonist DCS on emotional processing, memory and stress tasks

Full description

The aim of the present study is to assess the effect of DCS on emotional processing relevant to antidepressant drug activity. For this, 40 healthy volunteers will be recruited to the study and randomized to receive a single session of 250mg DCS or placebo. 3 hours and 24 hours after active drug/placebo administration, the effects of emotional processing via the use of cognitive tasks will be assessed. Also, given the important role of DCS in memory and stress, we also include tasks to explore changes in autobiographical memory and in psychological and physiological measures of stress and arousal.

Enrollment

40 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male or female
Willing and able to give informed consent for participation in the study
Body mass index (BMI) within the range of 19-30kg/m2
Sufficiently fluent English to understand and complete the task

Exclusion criteria

Currently take any psychoactive medication.
Have taken any CNS-active medication during the last 6 weeks.
Currently take any medication with cycloserine, ethionamide or isoniazid
Have suffered from any past or current psychiatric disorder (e.g. depression, anxiety)
Have lifetime history of epilepsy or other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
Have history of heart disease, significant hypertension
Have history of Megaloblastic Anaemia, Sideroblastic Anaemia
Have history of kidney disease with reduction in kidney function
Have severe renal impairment
Have suffered from lactose intolerance
Are currently pregnant, breastfeeding or trying to get pregnant
Have a current or past history of drug or alcohol dependency
Have participated in a psychological or medical study involving the use of medication within the last 3 months
Have previously participated in a study using the same, or similar, emotional processing tasks
Smoke more than 5 cigarettes per day
Have dyslexia (given the nature of the computer tasks)